MTOR and renal cell carcinoma: Meanwhile, through multilevel genomics-based taxonomy of 894 RCC samples, Chen et al. (2016) demonstrated that the PI3K/AKT/mTOR signaling pathway could distinguish between RCC subtypes, such as clear cell, chromophobe and papillary RCC; however the prognostic value was not investigated.